This local biotech is shutting down...

Gaithersburg vaccine maker Novavax reports earnings tomorrow.

Here's what industry analysts told me last week re: its Covid vaccine / competing with the mRNA shots from Pfizer Inc.-BioNTech SE and Moderna... bizj.us/1qjw54

HEALTH CARE UNION UPDATE: The unionized medical residents at GW University are moving forward with contract negotiations.

But the nurses at UHS, Inc.-owned GWHospital haven't yet gotten to the table. Here's why: bizj.us/1qju3n

Silver Spring’s United Therapeutics closed the third quarter projecting to double revenue, to $4 billion, by 2025. Here's why its CEO is so upbeat. bizjournals.com/washington/new…

HEALTH CARE EXEC NEWS: Kaiser Permanente has named its next leader... bizj.us/1qjtoy

BREAKING: Gaithersburg’s Novavax just scored a crucial Covid-19 vaccine approval from EU Medicines Agency bizj.us/1qjtox

NEW: Amgen 🧪🔬🧬’s layoffs following its Horizon acquisition won’t immediately affect the company’s D.C.-area presence.

But some things — including re: its Montgomery County real estate — are TBD... bizj.us/1qjs8l

The latest in Greater Washington biotech: Sensei Bio faces a delisting threat and _NexImmune_ just regained Nasdaq compliance.

Oh, and the cuts (to real estate, staff, programs, expenses, etc.) continue. bizj.us/1qjs4s

Anddd we're back on the beat at Washington Business Journal! Looking forward to catching up with y'all. #health #health care #hospitals #startups #biotech #lifesciences #cannabis

The life sciences sector faces a big roadblock to funding after a Covid-driven capital influx.

But the money is still on the sidelines — and slowly coming back in.

Now, companies like Gaithersburg's Immunomic Therapeutics are charting their own paths to secure it. bizj.us/1qj04f

Exclusive: Rose: Smarter Mental Health founder Kavi Misri has started a new company with a platform for #employers — to help their #employees catch and manage metabolic conditions like #diabetes .

It just raised $$ and has its eyes on more... bizj.us/1qj04g

Funding and the public markets have been tough for biotech companies. But some, like Rockville’s Immunomic Therapeutics, are navigating less traditional routes to capital. bizjournals.com/washington/new…

What Novavax is doing “to cut through this really difficult time in the company’s history,” per CEO John Jacobs: bizj.us/1qizko

DEEP DIVE: Ascension's health 'village' on the old Providence Hospital campus isn't going to happen.

Here's what it all means for D.C. health care, in this week's Washington Business Journal cover: bizj.us/1qiybh